Jounce Therapeutics
JNCE
#9239
Rank
โ‚น9.24 B
Marketcap
โ‚น171.16
Share price
0.00%
Change (1 day)
-42.16%
Change (1 year)

Revenue for Jounce Therapeutics (JNCE)

Revenue in 2022 (TTM): โ‚น6.78 Billion

According to Jounce Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น7.46 Billion. In 2021 the company made a revenue of โ‚น2.00 Billion a decrease over the revenue in the year 2020 that were of โ‚น4.55 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jounce Therapeutics from 2016 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น6.78 B238.81%
2021 โ‚น2.00 B-56.07%
2020 โ‚น4.55 B-56.76%
2019 โ‚น10.54 B131.3%
2018 โ‚น4.55 B-0.34%
2017 โ‚น4.57 B80.97%
2016 โ‚น2.52 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA